Microba Life Sciences Limited (ASX: MAP)
Sector: Health Care
Market cap: A$26M (as of 2 Nov 2026)
Microba is a commercial stage company with leading technology for measuring the human gut microbiome.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 30 Sept 2026 | Mercer Investments (Australia) Limited as RE of Mercer Australian Small Companies Fund, Mercer Investments (Australia) Limited as RE of Mercer DG (ex p) Trust, Mercer Investments (Australia) Limited as Trustee of WSSP Australian Equities Trust | Increase | 7.586% → 8.725% | Filing ↗ |
| 14 July 2026 | Mercer Investments (Australia) Limited as RE of Mercer Australian Small Companies Fund, Mercer Investments (Australia) Limited as RE of Mercer DG (ex p) Trust, Mercer Investments (Australia) Limited as Trustee of WSSP Australian Equities Trust | Increase | 6.37% → 7.586% | Filing ↗ |
| 23 June 2026 | SA Microba Holdings Pty Ltd | Exit | — | Filing ↗ |
| 19 June 2026 | Perennial Value Management Limited | Increase | 12.02% → 13.62% | Filing ↗ |
| 12 Nov 2025 | Mercer Investments (Australia) Limited as RE of Mercer Australian Small Companies Fund and Mercer Sustainable Plus Australian Shares Fund | Increase | 5.31% → 6.37% | Filing ↗ |
Director trades — on-market
Cash and runway
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 23 June 2025 | FY25 | $15.4m - $16m in FY25 revenue, and over >145% core product growth YoY. Sales and clinician adoption continuing to increase through a scalable product-accelerated growth model. | Filing ↗ |
Ask about MAP in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has MAP raised money in the last year, and at what discount?
- What was MAP's latest cash position and runway?
Loading MAP…